Case report
Open access
Sep 2026
Allogeneic CD19 CAR-NK cell therapy for a patient with relapsed and refractory lupus nephritis
To monitor changes in the clinical course and adverse events following allogeneic CD19 CAR-NK cell therapy in a patient with relapsed/refractory lupus nephritis (LN). This case report depicts a patient with severe LN refractory to available treatments (including prednisone, mycophenolate mofetil and belimumab) was trea...
Yu Tang, Yan-Run Wang, Wei Shi et al.
· Arthritis Research & Therapy · 0 citations